A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
More than 150,000 people with cancer come to Mayo Clinic each year. They find experts with extensive experience in the diagnosis and treatment of virtually every kind of cancer and the resources to provide excellent care tailored to their needs.
Rochester, MN Clinical Trial Location
Mayo Clinic Cancer Center
200 1st St SW,
Rochester, MN 55905